Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
Gynecol Endocrinol ; 29(7): 716-9, 2013 Jul.
Article En | MEDLINE | ID: mdl-23772785

Anorexia nervosa is a serious eating disorder that is associated with decreased bone mineral density and greater lifetime risk for fractures. This case-controlled study, analyzed single nucleotide polymorphisms of genes encoding vitamin D receptor, estrogen receptor alpha (ESR1), collagen type I and calcitonin receptor (CTR). Relationships between genotype and body mass index, cycling status and lumbar spine bone mineral density (LBMD) were determined in 40 adolescent girls with anorexia nervosa and 10 age-matched controls. The distribution of CTR-AluI genotypes differed between groups, but this polymorphism was not associated with LBMD Z-score. Distribution of ESR1-XbaI genotypes did not differ between groups, but the AA genotype was associated with decreased LBMD Z-score (≤-1) (OR = 24.79, 95% CI, 1.01-606.08). Carriers of the A allele were more likely to have decreased LBMD Z-scores compared with carriers of the G allele (OR = 4.12, 95% CI, 1.23-13.85, p = 0.022). In conclusion, our study shows that anorexic patients with wild-type genotype ESR-XbaI receptor are in greater risk for decreased BMD in relation to those with the mutated gene. Prompt recognition of these patients is crucial because early administration of the proper therapeutic treatment may contribute to the prevention of adverse sequelae on bone metabolism.


Anorexia Nervosa/genetics , Bone Density/genetics , Estrogen Receptor alpha/genetics , Osteoporosis/genetics , Receptors, Calcitonin/genetics , Receptors, Calcitriol/genetics , Receptors, Collagen/genetics , Adolescent , Anorexia Nervosa/complications , Case-Control Studies , Child , Female , Genetic Predisposition to Disease , Humans , Integrin alpha2beta1 , Lumbosacral Region , Osteoporosis/complications , Pilot Projects , Polymorphism, Single Nucleotide , Risk Factors , Young Adult
2.
J Obstet Gynaecol ; 27(6): 597-600, 2007 Aug.
Article En | MEDLINE | ID: mdl-17896259

We set out to evaluate the safety and efficacy of the proposed misoprostol regimen in women with previous multiple caesarean sections. This was a retrospective cohort study of 21 women with more than one caesarean section who underwent termination of pregnancy (TOP) with 400 mug of vaginal misoprostol followed by 200 mug/6 h (max 800 mug). The complete abortion rate was 12/21 (57.14%) and six (28.57%) women had an incomplete abortion. Three TOPs (14.29%) failed. In the first trimester group, only 3/9 (33.34%) aborted completely, while (9/12) 75% second trimester patients aborted completely. There were no major complications. The proposed regimen is considered safe and reasonably effective in second trimester TOPs in women with previous multiple caesarean sections. In first trimester patients, the possibility of manual vacuum aspiration (MVA) should be discussed during counselling, or a higher dose should be used as the effectiveness is low.


Abortifacient Agents, Nonsteroidal/administration & dosage , Abortion, Induced/methods , Misoprostol/administration & dosage , Administration, Intravaginal , Adult , Cesarean Section, Repeat , Cohort Studies , Female , Humans , Pregnancy , Pregnancy Trimester, First , Pregnancy Trimester, Second , Retrospective Studies , Treatment Outcome
...